 |
|
| LC-MS Application Notes: Keyword Index Page |
| The following listing is an index of keywords that are found in our printed LC/MS application notes. |
|
To view the application note where references to the selected keyword are found, scroll down this page (or select the first letter of a keyword to go to that letter section), and then select any of the numbered links to the right of the keyword listing.
[Note: Numbered links on the right of each keyword correspond to the number of the application note]
|
|
|
|
| ABCDEFGHIJKLMNOPQRSTUVWXYZ |
|
|
|
| A |
|
|
|
|
|
| Keyword: |
|
Application note(s) where keyword is used: |
|
|
|
| Absolute Quantitation |
|
451 |
|
|
|
| Accela |
|
389, 391, 393, 402, 405, 406, 407, 410, 411, 417, 418, 419, 420, 423, 428, 432, 433, 439, 453, 455, 467 |
|
|
|
| Accuracy |
|
308, 309, 314, 319, 334, 337, 344, 347, 355 |
|
|
|
| Accurate Mass |
|
344, 367, 30162 |
|
|
|
| Acrylamide |
|
319 |
|
|
|
| Active Pharmaceutical Ingredient |
|
441 |
|
|
|
| ADME/Tox |
|
345, 346, 359,413,415, 422 |
|
|
|
| Advion NanoMate |
|
335 |
|
|
|
| Adrenal Disorders |
|
427 |
|
|
|
| Adrenocortical Dysfunction |
|
427 |
|
|
|
| Antibotic |
|
337, 354, 372, 407, 435 |
|
|
|
| APCI |
|
314, 319, 336 |
|
|
|
| APPI |
|
376 |
|
|
|
| AQUA |
|
451 |
|
|
|
| Aria TLX-1 |
|
436, 442, 460, 464, 465, 473, 474 |
|
|
|
| Aria TLX-2 |
|
427, 429 |
|
|
|
| Aria TLX 4 |
|
398, 457, 458 |
|
|
|
| ASTM D6751 |
|
389 |
|
|
|
| Autoradiography (QWBA) |
|
413 |
|
|
|
|
return to top
|
|
|
|
|
|
|
|
| B |
|
|
|
|
|
| Keyword: |
|
Application note(s) where keyword is used: |
|
|
|
| Background reduction |
|
362, 400 |
|
|
|
| Bioanalysis |
|
398 ,447, 448, 436, 446, 394, 433 |
|
|
|
| Biobasic Columns |
|
414 |
|
|
|
| Biodistribution |
|
415 |
|
|
|
| Biomarkers |
|
380, 431,443, 444,459 |
|
|
|
| BioWorks |
|
335, 345, 353, 404 |
|
|
|
| Blue-green algea |
|
379 |
|
|
|
|
return to top
|
|
|
|
|
|
| C |
|
|
| Keyword: |
|
Application note(s) where keyword is used: |
|
|
|
| Cancer Cell Extracts |
|
400 |
|
|
|
| Cardiac Disease |
|
343 |
|
|
|
| Clinical Analysis |
|
382, 446 |
|
|
|
| Clinical Research |
|
427, 429, 457 |
|
|
|
| Clinical Samples |
|
444, 436 |
|
|
|
| Clinical Toxicology |
|
449, 394, 433 |
|
|
|
| Cohesive Aria |
|
354 |
|
|
|
| Collision Induced Dissociation (CID) |
|
374, 406 |
|
|
|
| Concomitant Medication |
|
440 |
|
|
|
| Cone wash |
|
371 |
|
|
|
| Confirmation |
|
337, 346, 350, 354 |
|
|
|
| Constant Neutral Loss (CNL) |
|
348, 349, 359 |
|
|
|
| Cross-talk |
|
323, 351, 355 |
|
|
|
| Cyanuric Acid |
|
424 |
|
|
|
|
return to top
|
|
|
|
| D |
|
|
|
|
|
| Keyword: |
|
Application note(s) where keyword is used: |
|
|
|
| Data Dependent |
|
345, 349, 353, 359, 368, 399, 438 |
|
|
|
| Data Dependent acquisition |
|
323, 330, 334, 335, 336, 337, 338, 343, 344, 345 |
|
|
|
| DEHP |
|
413 |
|
|
|
| DHB, DHB/DMA |
|
471 |
|
|
|
| Differential Expression |
|
343, 344, 345 |
|
|
|
| Discovery PK |
|
395, 406, 422 |
|
|
|
| DMPK |
|
441 |
|
|
|
| Drinking Water Analysis |
|
434, |
|
|
|
| Drug Discovery |
|
345, 349, 359, 362, 406, 422, 458 |
|
|
|
| Drug Metabolism |
|
348, 349, 369, 422 |
|
|
|
| Drug Screening |
|
350, 394 |
|
|
|
| Drugs of Abuse |
|
383, 390, 423, 439 |
|
|
|
|
return to top
|
|
|
|
| E |
|
|
|
|
|
| Keyword: |
|
Application note(s) where keyword is used: |
|
|
|
| Electron Capture (ECD) |
|
360, 365 |
|
|
|
| Endogenous Peptides |
|
443, 444 |
|
|
|
| Enhanced Mass Resolution |
|
314 |
|
|
|
| Environmental Application |
|
331, 341, 351, 397, 453 |
|
|
|
| EPA |
|
411, 454 |
|
|
|
| EQuan |
|
373, 391, 435, 437 |
|
|
|
| ESI |
|
375 |
|
|
|
| Estriadol |
|
388 |
|
|
|
| Estrogenic Compounds |
|
455 |
|
|
|
| ETD |
|
463 |
|
|
|
| Exactive |
|
30162, 30163 |
|
|
|
| Exlusive List |
|
469 |
|
|
|
| European Pharmacopoeia (EP) |
|
393 |
|
|
|
|
return to top
|
|
|
|
| F |
|
|
|
|
|
| Keyword: |
|
Application note(s) where keyword is used: |
|
|
|
| FAIMS |
|
362, 382, 394, 395, 400, 410, 431, 440, 448 |
|
|
|
| FDA Method Validation |
|
308, 357 |
|
|
|
| Flavonoids |
|
312 |
|
|
|
| Food residue analysis |
|
361, 407, 442 |
|
|
|
| Food and Environmental |
|
377, 385, 424, 425, 30163 |
|
|
|
| Food Safety |
|
465, 473, 478 |
|
|
|
| Food Testing |
|
464 |
|
|
|
| Forensics Analysis |
|
366, 383, 384, 428, 432, 433 |
|
|
|
| FT-ICR-MS |
|
344, 360, 459 |
|
|
|
| FT-SIM |
|
368 |
|
|
|
|
return to top
|
|
|
|
| G |
|
| Keyword: |
|
|
Application note(s) where keyword is used: |
|
|
|
|
| GC-MS/MS |
|
|
388 |
|
|
|
|
| General Unknown Screening |
|
|
449 |
|
|
|
|
| Glucuronidation |
|
|
359 |
|
|
|
|
| Glyburide Incubation |
|
|
369 |
|
|
|
|
| Glycoproteins |
|
|
471 |
|
|
|
|
| Glycoproteomics |
|
|
463 |
|
|
|
|
| Glycosylation |
|
|
404 |
|
|
|
|
| GSH Conjugates |
|
|
430 |
|
|
|
|
|
return to top
|
|
|
|
| H |
|
|
|
|
|
| Keyword: |
|
|
Application note(s) where keyword is used: |
|
|
|
| HCD |
|
445 |
|
|
|
| Higher Energy Collisional Dissociation (HCD) |
|
420, 421 |
|
|
|
| Heavy Peptide |
|
408 |
|
|
|
| Herbicides |
|
434, 437, 453 |
|
|
|
| High Resolution |
|
310, 343, 344, 345, 367 |
|
|
|
| High-Temperature |
|
453 |
|
|
|
| High Throughput |
|
308, 309, 314, 323, 330, 345, 353, 354, 355, 382, 405, 446, 456 |
|
|
|
| High-resolution mass measurements |
|
375, 30162 |
|
|
|
| Honey |
|
360 |
|
|
|
| HSRM |
|
347, 354, 355, 377, 380, 385, 387, 412, 425, 451 |
|
|
|
| High Mass Accuracy |
|
30121 |
|
|
|
| Human Plasma |
|
343, 344 |
|
|
|
| High Resolution |
|
30121, 30163 |
|
|
|
| Human Serum Complex |
|
380 |
|
|
|
| Hypercarb LC Column |
|
453 |
|
|
|
| Hypersil GOLD Columns |
|
370, 371, 373, 385, 389, 392, 393, 405, 410, 411, 414, 417, 418, 432, 433, 434, 439, 444, 455 |
|
|
|
|
return to top
|
|
|
|
| I |
|
|
|
|
|
| Keyword: |
|
|
Application note(s) where keyword is used: |
|
|
|
| Ibuprofen |
|
393 |
|
|
|
| Illicit Drug |
|
419 |
|
|
|
| Increased selectivity |
|
362, 394, 431 |
|
|
|
| Infant Formula |
|
474 |
|
|
|
| Improved sensitivity |
|
310, 399, 438 |
|
|
|
| Impurity Identification |
|
376, 395 |
|
|
|
| Interference Removal |
|
440, 448 |
|
|
|
| Inter day Validation |
|
426 |
|
|
|
| In-vitro |
|
348, 359 |
|
|
|
| Ion Chromatography |
|
454 |
|
|
|
| Ionization Mechanisms |
|
374, 375 |
|
|
|
| Ion Mobility |
|
395, 431 |
|
|
|
| Ion Trap Mass Spectrometer |
|
334, 335, 338, 343, 345, 346 |
|
|
|
| IRMPD |
|
360 |
|
|
|
| Isotope Search |
|
430 |
|
|
|
| iSRM |
|
468 |
|
|
|
| Iterative method building |
|
470 |
|
|
|
| iTRAQ |
|
421, 445 |
|
|
|
|
return to top
|
|
|
|
|
|
| K |
|
|
| Keyword |
|
|
|
|
|
| KingFisher |
|
459 |
|
|
|
|
|
|
return to top
|
|
|
|
| L |
|
|
|
|
|
| Keyword: |
|
|
Application note(s) where keyword is used: |
|
|
|
| Labeled Standards |
|
408 |
|
|
|
| Labile sample analysis |
|
357, 364, |
|
|
|
| LC/MS |
|
308, 309, 323, 336, 337, 343, 347, 353, 354, 355 |
|
|
|
| LC/MS/MS |
|
308, 309, 323, 336, 337, 347, 355, 358, 379, 383, 391, 414, 422, 424, 429, 435 |
|
|
|
| LCQ |
|
312 |
|
|
|
| LCQ Deca XP Plus |
|
414 |
|
|
|
| LCQ Fleet |
|
392 |
|
|
|
| LCQ Series |
|
312 |
|
|
|
| Linear Dynamic Range |
|
309, 314, 323, 330, 447 |
|
|
|
| Linear Ion Trap |
|
323, 354, 363, 422, 462 |
|
|
|
| Lipids |
|
334, 336, 367 |
|
|
|
| Loperamide |
|
410 |
|
|
|
| Low Molecular Weight (LMW) |
|
344 |
|
|
|
| Low Sample Carryover |
|
330 |
|
|
|
| LSD |
|
383, 432 |
|
|
|
| LTQ |
|
334, 335, 338, 343, 345, 350, 357, 360 |
|
|
|
| LTQ FT |
|
343, 344, 345, 346, 347, 360, 365, 368 |
|
|
|
| LTQ FT Ultra |
|
30121, 459 |
|
|
|
| LTQ Velos |
|
462 |
|
|
|
| LTQ Orbitrap |
|
367, 386, 406, 418, 421, 430 |
|
|
|
| LTQ Orbitrap XL |
|
417, 443, 444, 445, 469, 471 |
|
|
|
| LTQ XL |
|
395, 404, 406, 413, 415, 422, 452 |
|
|
|
| LXQ |
|
363, 366, 369, 410, 449, 467 |
|
|
|
|
return to top
|
|
|
|
| M |
|
|
|
|
|
| Keyword: |
|
|
Application note(s) where keyword is used: |
|
|
|
|
|
|
| Magic Mushroom |
|
428 |
|
|
|
| Magnetic Beads |
|
459 |
|
|
|
| MALDI |
|
357, 364, 413, 415, 422, 471 |
|
|
|
| MALDI LTQ Orbitrap |
|
450 |
|
|
|
| Mass Defect Filter |
|
418, 430 |
|
|
|
| Mass Frontier |
|
369, 392, 420, 441 |
|
|
|
| MDMA |
|
419 |
|
|
|
| Metabolism |
|
309, 314, 323, 334, 336, 346, 358, 359, 367, 369, 383, 413, 417, 418, 422 |
|
|
|
| Metabolomics |
|
312, 367, 392, 300143, 413, 422, 441 |
|
|
|
| Methamphetamine |
|
419 |
|
|
|
| Metanephrines |
|
460 |
|
|
|
| MetWorks Software |
|
369, 417, 430 |
|
|
|
| Mycotoxins |
|
381 |
|
|
|
| Microcystin |
|
379 |
|
|
|
| Mitosis |
|
450 |
|
|
|
| MS3 |
|
312, 335, 338, 350, 353, 366 |
|
|
|
| MSn |
|
312, 335, 338, 343, 353, 392, 413 |
|
|
|
| MSQ Plus |
|
402, 419, 423, 428, 432, 433, 439, 456 |
|
|
|
| Multicomponent Assays |
|
351 |
|
|
|
| Multiple Mass Defect Filters |
|
417 |
|
|
|
|
return to top
|
|
|
|
| N |
|
|
|
|
|
| Keyword: |
|
|
Application note(s) where keyword is used: |
|
|
|
| Nanospray |
|
335, 338, 343, 353, 368 |
|
|
|
| Natural Products |
|
312, 392, 420 |
|
|
|
| Negative CI |
|
388 |
|
|
|
| Neutral Loss |
|
338 |
|
|
|
| N-Glycosylation |
|
463 |
|
|
|
| Nitrofurans |
|
358 |
|
|
|
| Nitrosocysteine |
|
357 |
|
|
|
| Normal-phase chromatography |
|
336 |
|
|
|
| Nuclear Pore Complex |
|
450 |
|
|
|
|
return to top
|
|
|
|
| O |
|
|
| Keyword: |
|
Application note(s) where keyword is used: |
|
|
|
| Online concentration |
|
435 |
|
|
|
| Opiates |
|
461 |
|
|
|
| Orbitrap XL ETD |
|
463 |
|
|
|
| Oxidative modifications |
|
357 |
|
|
|
|
return to top
|
|
|
|
|
|
| P |
|
|
| Keyword: |
|
Application note(s) where keyword is used: |
|
|
|
|
|
|
| Parallel Detection |
|
346 |
|
|
|
| Parkinson's Disease |
|
436 |
|
|
|
| PDA |
|
346 |
|
|
|
| Peptides |
|
338, 343, 344, 353, 354, 357, 421, 445, 448 |
|
|
|
| Peptide Sequencing |
|
386, 462 |
|
|
|
| Pesticides |
|
323, 351, 355, 373, 391 |
|
|
|
| Pesticide Residue |
|
355, 387, 425, 30163 |
|
|
|
| Petroleum Analysis |
|
371 |
|
|
|
| Pharmaceuticals |
|
309, 347, 405, 406 |
|
|
|
| Pharmacokinetic Applications |
|
314, 410, 406, 422 |
|
|
|
| Phenols |
|
411 |
|
|
|
| Phosphopeptide |
|
450, 459 |
|
|
|
| Phosphorylation |
|
404, 445, 450 |
|
|
|
| Pinpoint |
|
468 |
|
|
|
| Plasma |
|
308, 309, 314, 343, 344, 347 |
|
|
|
| Polarity Switching |
|
30162 |
|
|
|
| Porous Graphite |
|
463 |
|
|
|
| Positive List System |
|
387 |
|
|
|
| Post-translational Modification (PTMs) |
|
338, 344, 360, 404, 459 |
|
|
|
| PQD |
|
452 |
|
|
|
| Precision |
|
308, 309, 310, 314, 319, 334, 337, 339, 347 |
|
|
|
| Precursor Ion Fingerprinting (PIF) |
|
441 |
|
|
|
| ProSight PTM |
|
344, 365 |
|
|
|
| Protein Fractionation |
|
343 |
|
|
|
| Protein glycosylation |
|
335 |
|
|
|
| Protein Identification |
|
335, 343, 344, 345, 353, 386, 462 |
|
|
|
| Proteome Discoverer |
|
462, 469 |
|
|
|
| Proteomics |
|
336, 343, 344, 345, 353, 355, 360, 363, 368, 380, 421, 445, 450, 452, 462, 470 |
|
|
|
| Proteomic Workflow |
|
469 |
|
|
|
| Proteotypic Peptides |
|
408 |
|
|
|
| Pseudoephedrine Identification |
|
419 |
|
|
|
| Psylocin |
|
428 |
|
|
|
| Psylocybin |
|
428 |
|
|
|
| PTMs |
|
338, 344, 386 |
|
|
|
| Pulse Counting |
|
447 |
|
|
|
|
return to top
|
|
|
|
| Q |
|
|
|
|
|
| Keyword: |
|
|
Application note(s) where keyword is used: |
|
|
|
|
| QED |
|
|
387, 412, 437, 438 |
|
|
|
|
| Quantitation |
|
|
308, 309, 310, 314, 319, 323, 334, 336, 337, 346, 347, 350, 351, 353, 354, 355, 377, 421, 440, 445, 448, 452, 456 |
|
|
|
|
| Quantitative analysis |
|
|
358, 360 |
|
|
|
|
| QuickQuan software |
|
|
458 |
|
|
|
|
|
return to top
|
|
|
|
| R |
|
|
|
|
|
| Keyword: |
|
|
Application note(s) where keyword is used: |
|
|
|
| Reproducibility |
|
426 |
|
|
|
| Robustnes |
|
308, 426 |
|
|
|
|
return to top
|
|
|
|
| S |
|
|
|
|
|
| Keyword: |
|
|
Application note(s) where keyword is used: |
|
|
|
| Salivary Peptide |
|
451 |
|
|
|
| Scalability |
|
401 |
|
|
|
| Scan Speed |
|
30162 |
|
|
|
| Selectivity |
|
382, 400, 446, 456 |
|
|
|
| Seminal Plasma |
|
469 |
|
|
|
| Sensitivity |
|
308, 309, 310, 314, 319, 323, 334, 335, 336, 337, 338, 344, 345, 347, 353, 354, 355, 397, 401, 425, 439, 456, 462 |
|
|
|
| Sialylated glycans |
|
471 |
|
|
|
| SIEVE Software |
|
420, 443, 444 |
|
|
|
|
|
|
| Single quadrupole MS |
|
371 |
|
|
|
| SIM Quantitation |
|
349 |
|
|
|
| Simvastatin |
|
402 |
|
|
|
| Size Exclusion Chromatography (SEC) |
|
414 |
|
|
|
| Solid phase extraction (SPE) |
|
372, 397, 414, 466 |
|
|
|
| Speed |
|
401 |
|
|
|
| SRM |
|
309, 310, 319, 323, 336, 337, 347, 350, 351, 354, 355, 361, 379, 387, 388, 390, 407, 408, 438, 443, 459, 470 |
|
|
|
| Structure Elucidation |
|
338, 367, 399, 406 |
|
|
|
| Sulfonamides |
|
435 |
|
|
|
| Suncreens |
|
455 |
|
|
|
| Surveyor Autosampler |
|
330 |
|
|
|
| Surveyor™HPLC |
|
309, 319, 323, 330, 337, 347, 348, 351, 355, 358, 361, 363, 366, 369, 371, 372, 380, 381, 385, 390, 392, 394, 397, 411, 414, 425, 430 |
|
|
|
| Surveyor MSQ Plus |
|
371, 389 |
|
|
|
|
|
|
return to top
|
|
|
|
| T |
|
|
|
|
|
| Keyword: |
|
|
Application note(s) where keyword is used: |
|
|
|
| Targeted Quantitative Proteomics |
|
412, 447, 468, 470 |
|
|
|
| Targeted Metabolomics |
|
431 |
|
|
|
| Targeted Protein |
|
380, 408 |
|
|
|
| Ternary Solvent Gradient |
|
423 |
|
|
|
| Tetrahydrocannabinol (THC) |
|
433 |
|
|
|
| Therapeutic Drug Monitoring |
|
384 |
|
|
|
| Tissue Imaging |
|
413, 415, 422 |
|
|
|
| TMT |
|
452 |
|
|
|
| Top-Down Proteomics Analysis |
|
344, 365 |
|
|
|
| Toxicology |
|
384, 428 |
|
|
|
| Tox ID Software |
|
449, 453, 467 |
|
|
|
| ToxSpec Analyzer |
|
449, 467 |
|
|
|
| Transcend TLX-1 |
|
461 |
|
|
|
| Triazines |
|
434, |
|
|
|
| Triple play |
|
343, 345 |
|
|
|
| Triple Quadrupole MS |
|
309, 319, 468 |
|
|
|
| TriPlus Autosampler |
|
381 |
|
|
|
| TSQ Quantum Access |
|
407, 408, 434, 437, 442, 454, 457 |
|
|
|
| TSQ Quantum |
|
309, 310, 323, 351, 383, 384, 391 |
|
|
|
| TSQ Quantum Discovery |
|
314, 337, 349, 355, 358, 359, 377, 385, 390, 403 |
|
|
|
| TSQ Quantum GC |
|
387, 388 |
|
|
|
| TSQ Quantum Ultra AM |
|
374, 375, 376 |
|
|
|
| TSQ Quantum Ultra |
|
336, 347, 348, 349, 354, 362, 372, 373, 379, 380, 382, 394, 397, 399, 400, 412, 416, 424, 425, 427, 429, 436, 438, 443, 446, 458, 461, 464, 465, 466
|
|
|
|
| TSQ Vantage |
|
426, 447, 451, 460, 468, 473, 474 |
|
|
|
| TurboFlow Technology |
|
416, 398, 436, 440, 442, 457, 458, 460, 461, 464, 465, 473, 474 |
|
|
|
| Turbulent-flow extraction |
|
354 |
|
|
|
|
return to top
|
|
|
|
|
|
| U |
|
|
| Keyword: |
|
Application note(s) where keyword is used: |
|
|
|
| UGTs |
|
359 |
|
|
|
| U-HPLC |
|
393, 402, 406, 423 |
|
|
|
| UV Absorbers |
|
455 |
|
|
|
| V |
|
|
| Keyword: |
|
Application note(s) where keyword is used: |
|
|
|
| Veterinary drugs |
|
361, 442 |
|
|
|
| Vitamin D |
|
416 |
|
|
|
|
return to top
|
|
|
|
|
|
| W |
|
|
| Keyword: |
|
Application note(s) where keyword is used: |
|
|
|
| Water Analysis |
|
391, 411, 437, 454, 455, 466 |
|
|
|
| Whole Blood |
|
461 |
|
|
|
| Z |
|
|
| Keyword: |
|
Application note(s) where keyword is used: |
|
|
|
| Zero Cross-talk |
|
355 |
|
|
|
|
|
|
return to top
|
|
 |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
| |
| |
|
|
|
|
0 Articoli